No Data
No Data
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Express News | Atara Biotherapeutics Inc - Pierre Fabre to Assume Costs for FDA Remediation to Support Bla Resubmission for Tab-Cel - SEC Filing
Atara Biotherapeutics Transfers Full Manufacturing Responsibility For Tabelecleucel To Pierre Fabre; Now Entitled To Receive Up To $550M In Additional Potential Milestone Payments Upon Achieving Certain Regulatory And Commercial Milestones Relating To...
Express News | Atara Biotherapeutics Inc - Bio to Receive up to $550 Mln in Milestone Payments - SEC Filing
Express News | Atara Biotherapeutics Inc - on March 31, Entered Amendment to Commercialization Agreement With Pierre Fabre - SEC Filing
Atara Biotherapeutics Announces CFO Departure and New Appointment
kingrotch : thank you for your work


真名有晨 : Thank you very much
Please take care and rest.
iluvpoptarts : sry doc. I'm too busy counting the money your making me too look. muha
IamBadNewz : @Jaguar8 Been waiting (im)patiently for a pop on CGTX given the recent conference and news of insider buying but price hasn’t reacted. Your thoughts?
Jaguar8 OP IamBadNewz : You have to be patient
View more comments...